NDRA with it's consistent dilution has been a little rough.
Had a small position go 88% down and that was my cue to toss more in to fix the average price.
I do believe the clinical trials pass with great results and this will be used complementary to MRI and other tech/procedures that are currently done and more that will be created into the future.